Pap Tedavisinde Ortaya Çıkan Problemler ve Çözümleri
Özet
Pozitif hava yolu basıncı (PAP) tedavisi, obstrüktif uyku apnesi sendromunun (OSAS) yönetiminde altın standart olarak kabul edilmekle birlikte, uzun vadeli hasta uyumu noktasında çeşitli zorluklar barındırmaktadır. Araştırmalar, hastaların önemli bir kısmının zaman içinde tedaviyi bıraktığını göstermektedir. Tedaviye uyumu olumsuz etkileyen faktörler; hasta/hastalık kaynaklı etmenler, maske/cihaz problemleri ve genel psikolojik durumlardan oluşmaktadır. İlk ayki deneyimler, hastanın motivasyonu ve Epworth Uykululuk Ölçeği skorları uyum üzerinde belirleyici rol oynarken; yaş, cinsiyet veya obezite derecesi gibi demografik verilerin doğrudan bir etkisi saptanmamıştır. Cihaz kullanımında sıkça karşılaşılan maskeden hava kaçağı, cilt lezyonları, burun kuruluğu ve yüksek basınç intoleransı gibi fiziksel problemler konforu düşürmektedir. Ayrıca, mid-fasyal hipoplazi, kuru göz ve nadiren beyin-omurilik sıvısı kaçağı gibi komplikasyonlar da literatürde yer almaktadır. Klostrofobi, anksiyete ve Kompleks Uyku Apnesi (CompSAS) gelişimi de süreci zorlaştıran diğer unsurlardır. Bu engelleri aşmak için APAP veya BİPAP gibi alternatif modalitelerin yanı sıra ısıtıcı-nemlendirici ünitelerin kullanımı ve kişiye özel maske tasarımları klinik başarıyı artırmaktadır. Sonuç olarak, hastaların tedavi başlangıcında yakından takibi, kapsamlı eğitimi ve multidisipliner davranışsal müdahaleler altın standart olan bu tedavinin etkinliğini ve kalıcı başarısını sağlamada kritik öneme sahiptir.
Positive airway pressure (PAP) therapy stands as the gold standard treatment for obstructive sleep apnea syndrome (OSAS), yet it presents significant challenges regarding long-term patient adherence. Research indicates that a substantial portion of patients discontinue therapy over time. Factors negatively affecting treatment compliance are categorized into patient/disease-related issues, mask/device malfunctions, and general psychological factors. While initial experiences, patient motivation, and Epworth Sleepiness Scale scores play a decisive role in compliance, demographic variables such as age, gender, or obesity levels have no direct impact. Physical challenges encountered during device usage, including mask leaks, skin lesions, nasal dryness, and high-pressure intolerance, severely reduce patient comfort. Furthermore, complications such as mid-facial hypoplasia, dry eyes, and rarely, cerebrospinal fluid leaks are documented in literature. The emergence of claustrophobia, anxiety, and Complex Sleep Analysis (CompSAS) further complicates the process. To overcome these obstacles, utilizing alternative modalities like APAP or BiPAP, incorporating heated-humidifier units, and designing customized masks enhance clinical outcomes. Consequently, close follow-up during the initial phase, comprehensive patient education, and multidisciplinary behavioral interventions are critical to achieving sustainable success and optimizing the efficacy of this gold standard therapy.
Referanslar
Galetke,W., Puzzo,L., Priegnitz, C. (2011). Long-term therapy with continuous positive airway pressure in obstructive sleep apnea: adherence, side effects and predictors of withdrawal–a ‘real-life’study. Respiration, 82(2), 155-161.
Gay,P., Weaver,T.,Iber,C. (2006). Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults. Sleep, 29(3), 381-401.
Ulander, M., Johansson, P., Franzen, K. (2009). Side effects of CPAP treatment at 2 weeks and 6 months and their correlation to adherence.
Sawyer, A. M., Gooneratne, N. S., Marcus, C. L.(2011). A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions. Sleep medicine reviews, 15(6), 343-356.
Piper, A. J., Wang, D., Yee, B. J. (2008). Randomised trial of CPAP vs bilevel support in the treatment of obesity hypoventilation syndrome without severe nocturnal desaturation. Thorax, 63(5), 395-401.
Mokhlesi, B., Tulaimat, A., Evans, A. T.(2006). Impact of adherence with positive airway pressure therapy on hypercapnia in obstructive sleep apnea. Journal of Clinical Sleep Medicine, 2(01), 57-62.
Lloberes, P., Martí, S., Sampol, G.(2004). Predictive factors of quality-of-life improvement and continuous positive airway pressure use in patients with sleep apnea-hypopnea syndrome: study at 1 year. Chest, 126(4), 1241-1247.
Steier, J., Jolley, C. J., Seymour, J.(2009). Neural respiratory drive in obesity. Thorax, 64(8), 719-725.
Hollier, C. A., Harmer, A. R., Maxwell, L. J. (2014). Moderate concentrations of supplemental oxygen worsen hypercapnia in obesity hypoventilation syndrome: a randomised crossover study. Thorax, 69(4), 346-353.
Budhiraja, R., Parthasarathy, S., Drake, C. L. (2007). Early CPAP use identifies subsequent adherence to CPAP therapy. Sleep, 30(3), 320-324.
Scharf, S. M., Seiden, L., DeMore, J. (2004). Racial differences in clinical presentation of patients with sleep-disordered breathing. Sleep and Breathing, 8(4), 173-183.
Joo, M. J., & Herdegen, J. J. (2007). Sleep apnea in an urban public hospital: assessment of severity and treatment adherence. Journal of Clinical Sleep Medicine, 3(3), 285-288.
Shannon, D. C., Marsland, D. W., Gould, J. B.(1976). Central hypoventilation during quiet sleep in two infants. Pediatrics, 57(3), 342-346.
Li, H. Y., Engleman, H., Hsu, C. Y. (2005). Acoustic reflection for nasal airway measurementin patients with obstructive sleep apnea-hypopnea syndrome. Sleep, 28(12), 1554-1559.
Nakata, S., Noda, A., Yagi, H.. (2005). Nasal resistance for determinant factor of nasal surgery in CPAP failure patients with obstructive sleep apnea syndrome. Rhinology, 43(4), 296.
Sugiura, T., Noda, A., Nakata, S. (2007). Influence of nasal resistance on initial acceptance of continuous positive airway pressure in treatment for obstructive sleep apnea syndrome. Respiration, 74(1), 56-60.
Anttalainen, U., Saaresranta, T., Vahlberg, T. (2014). Short-term medroxyprogesterone acetate in postmenopausal women with sleep-disordered breathing: a placebo-controlled, randomized, double-blind, parallel-group study. Menopause, 21(4), 361-368.
Straus, C., Trang, H., Becquemin, M. H. (2010). Chemosensitivity recovery in Ondine's curse syndrome under treatment with desogestrel. Respiratory physiology & neurobiology, 171(2), 171-174.
de Llano, L.A.P., Golpe, R., Piquer, M.O. (2005). Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Chest, 128(2), 587-594.
Kribbs, N. B., Pack, A. I., Kline, L. R. (2012). Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. American Review of Respiratory Disease.
Krieger, J. (1992). Long-term compliance with nasal continuous positive airway pressure (CPAP) in obstructive sleep apnea patients and nonapneic snorers. Sleep, 15(suppl_6), S42-S46.
Reeves-Hoche, M. K., Meck, R., & Zwillich, C. W. (1994). Nasal CPAP: an objective evaluation of patient compliance. American journal of respiratory and critical care medicine, 149(1), 149-154.
Mcardle, N., Devereux, G., Heidarnejad, H (1999). Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. American journal of respiratory and critical care medicine, 159(4), 1108-1114.
Barbé, F., Mayoralas, L. R., Duran, J. (2001). Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness: a randomized, controlled trial. Annals of internal medicine, 134(11), 1015-1023.
Beecroft, J., Zanon, S., Lukic, D. (2003). Oral continuous positive airway pressure for sleep apnea: effectiveness, patient preference, and adherence. Chest, 124(6), 2200-2208.
Chai‐Coetzer, C. L., Pathinathan, A.(2006). Continuous positive airway pressure delivery interfaces for obstructive sleep apnoea. Cochrane Database of Systematic Reviews, (4).
Lebret, M., Martinot, J. B., Arnol, N. (2017). Factors contributing to unintentional leak during CPAP treatment: a systematic review. Chest, 151(3), 707-719.
Andrade, R. G., Viana, F. M., Nascimento, J. A.(2018). Nasal vs oronasal CPAP for OSA treatment: a meta-analysis. Chest, 153(3), 665-674.
Deshpande, S., Joosten, S., Turton, A. (2016). Oronasal masks require a higher pressure than nasal and nasal pillow masks for the treatment of obstructive sleep apnea. Journal of Clinical Sleep Medicine, 12(9), 1263-1268.
Cheng, Y. L. & Chu, J. C. (2013). Application of rapid tooling to manufacture customized nasal mask cushion for continuous positive airway pressure (CPAP) devices. Rapid Prototyping Journal.
Hsu, D. Y., Cheng, Y. L., Bien, M. Y.(2015). Development of a method for manufacturing customized nasal mask cushion for CPAP therapy. Australasian physical & engineering sciences in medicine, 38(4), 657-664.
Bachour, A., Hurmerinta, K., & Maasilta, P. (2004). Mouth closing device (chinstrap) reduces mouth leak during nasal CPAP. Sleep medicine, 5(3), 261-267.
Bhat, S., Gushway-Henry, N., Polos, P. G. (2014). The efficacy of a chinstrap in treating sleep disordered breathing and snoring. Journal of Clinical Sleep Medicine, 10(8), 887-892.
Pépin, J. L., Leger, P., Veale, D. (1995). Side effects of nasal continuous positive airway pressure in sleep apnea syndrome: study of 193 patients in two French sleep centers. Chest, 107(2), 375-381.
Constantinidis, J., Knobber, D., Steinhart, H., Kuhn. (2000). Morphological and functional alterations in the nasal mucosa following nCPAP therapy. Hno, 48(10), 747-752.
White, D. E., Nates, R. J., & Bartley, J. (2017). Model identifies causes of nasal drying during pressurised breathing. Respiratory physiology & neurobiology, 243, 97-100.
White, D. E., Bartley, J., Shakeel, M. (2016). Nasal airway responses to nasal continuous positive airway pressure breathing: An in-vivo pilot study. Journal of biomechanics, 49(9), 1887-1890.
Dernaika, T., Tawk, M., Nazir, S.(2007). The significance and outcome of continuous positive airway pressure-related central sleep apnea during split-night sleep studies. Chest, 132(1), 81-87.
Bossi, R., Piatti, G., Roma, E. (2004). Effects of long‐term nasal continuous positive airway pressure therapy on morphology, function, and mucociliary clearance of nasal epithelium in patients with obstructive sleep apnea syndrome. The Laryngoscope, 114(8), 1431-1434.
Sommer, J. U., Kraus, M., Birk, R. (2014). Functional short-and long-term effects of nasal CPAP with and without humidification on the ciliary function of the nasal respiratory epithelium. Sleep and Breathing, 18(1), 85-93.
To, K. W., Chan, W. C., Choo, K. L.(2008). A randomized cross‐over study of auto‐continuous positive airway pressure versus fixed‐continuous positive airway pressure in patients with obstructive sleep apnoea. Respirology, 13(1), 79-86.
Ball, N., Gordon, N., Casal, E.(2011). Evaluation of auto bi-level algorithm to treat pressure intolerance in obstructive sleep apnea. Sleep and Breathing, 15(3), 301-309.
Bachour, A., & Maasilta, P. (2004). Mouth breathing compromises adherence to nasal continuous positive airway pressure therapy. Chest, 126(4), 1248-1254.
Weaver, T. E. (2006). Adherence to positive airway pressure therapy. Current opinion in pulmonary medicine, 12(6), 409-413.
Shepherd, K., Hillman, D., & Eastwood, P. (2013). CPAP-induced aerophagia may precipitate gastroesophageal reflux. Journal of Clinical Sleep Medicine, 9(6), 633-634.
Mystkowski, S.& Watson, N. (2007, January). Association of CPAP related aerophagia and gastroesophageal reflux disease. In Sleep (Vol. 30, pp. A325-A325). ONE WESTBROOK CORPORATE CENTER STE 920, WESTCHESTER, IL 60154 USA: AMER ACADEMY SLEEP MEDICINE.
Chhajed, P. N., Chhajed, T. P.,Strobel, W. (2004). Obstructive sleep apnea: therapies other than CPAP. JAPI, 52, 143-51.
Grunstein, R. R., Ho, K. Y., & Sullivan, C. E. (1991). Sleep apnea in acromegaly. Annals of internal medicine, 115(7), 527-532.
Galerneau, L. M., Pépin, J. L., Borel, A.L. (2016). Acromegaly in sleep apnoea patients: a large observational study of 755 patients. European Respiratory Journal, 48(5), 1489-1492.
Yiallourou, T. I., Daners, M. S., Kurtcuoglu, V.(2015). Continuous positive airway pressure alters cranial blood flow and cerebrospinal fluid dynamics at the craniovertebral junction. Interdisciplinary Neurosurgery, 2(3), 152-159.
Guerci, A. D., Shi, A. Y., Levin, H.(1985). Transmission of intrathoracic pressure to the intracranial space during cardiopulmonary resuscitation in dogs. Circulation research, 56(1), 20-30.
Rieley, W., Askari, A., Akagami, R.(2020). Immediate use of continuous positive airway pressure in patients with obstructive sleep apnea following transsphenoidal pituitary surgery: a case series. Journal of neurosurgical anesthesiology, 32(1), 36-40.
Hayirci, E., Yagci, A., Palamar, M.(2012). The effect of continuous positive airway pressure treatment for obstructive sleep apnea syndrome on the ocular surface. Cornea, 31(6), 604-608.
Berg, E. J., Davies, J. B., Buboltz, M. R.(2018). Late-onset bleb-associated endophthalmitis and continuous positive airway pressure. American journal of ophthalmology case reports, 10, 87-90.
Oikonomakis, K., Petrelli, M., Andreanos, K.(2017). Corneal neovascularization with associated lipid keratopathy in a patient with obstructive sleep apnea-hypopnea syndrome using a continuous positive airway pressure machine. Case reports in ophthalmology, 8(2), 416-420.
Kiekens, S., De Groot, V., Coeckelbergh, T. (2008). Continuous positive airway pressure therapy is associated with an increase in intraocular pressure in obstructive sleep apnea. Investigative ophthalmology & visual science, 49(3), 934-940.
Cohen, Y., Ben-Mair, E., Rosenzweig, E.(2015). The effect of nocturnal CPAP therapy on the intraocular pressure of patients with sleep apnea syndrome. Graefe's Archive for Clinical and Experimental Ophthalmology, 253(12), 2263-2271.
Fauroux, B., Lavis, J. F., Nicot, F., (2005). Facial side effects during noninvasive positive pressure ventilation in children. Intensive care medicine, 31(7), 965-969.
Tsuda, H., Almeida, F. R., Tsuda, T.(2010). Craniofacial changes after 2 years of nasal continuous positive airway pressure use in patients with obstructive sleep apnea. Chest, 138(4), 870-874.
Li, J., & Li, K. (2016). Effects of continuous positive airway pressure on middle ear pressure and acoustic stapedial reflex. Otolaryngology–Head and Neck Surgery, 155(2), 307-311.
Thom, J. J., Carlson, M. L., Driscoll, C. L. (2015). Middle ear pressure during sleep and the effects of continuous positive airway pressure. American journal of otolaryngology, 36(2), 173-177.
Dikmenoğlu ,N.(2019) Uyku ve uykuda solunum fizyolojisi.Köktürk O., Özol D. (Ed.) Uykuda solunum bozuklukları(s.1-12). Ankara: Nobel Tıp Kitabevi
Sturm, R., & Hattori, A. (2013). Morbid obesity rates continue to rise rapidly in the United States. International journal of obesity, 37(6), 889-891.
Kauppert, C. A., Dvorak, I., Kollert, F.(2013). Pulmonary hypertension in obesity-hypoventilation syndrome. Respiratory medicine, 107(12), 2061-2070.
Borel, J. C., Burel, B., Tamisier, R. (2013). Comorbidities and mortality in hypercapnic obese under domiciliary noninvasive ventilation. PLoS One, 8(1), e52006.
Castro-Añón, O., Pérez de Llano, L. A., De la Fuente Sánchez, S., Golpe, R., Méndez Marote, L., Castro-Castro, J., & González Quintela, A. (2015). Obesity-hypoventilation syndrome: increased risk of death over sleep apnea syndrome. PLoS One, 10(2), e0117808.
Lecube, A., Sampol, G., Lloberes, P. (2010). Asymptomatic sleep-disordered breathing in premenopausal women awaiting bariatric surgery. Obesity surgery, 20(4), 454-461.
Lazarus, R. S., & Folkman, S. (1984). Coping and Adaptation. Gentry, W. D. (Ed.) The Handbook of Behavioral Medicine (s. 282-325). New York: Guilford
Mechanick, J. I., Youdim, A., Jones, D. B., (2013). Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Surgery for Obesity and Related Diseases, 9(2), 159-191.
Mora, S., Cook, N., Buring, J. E., (2007). Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation, 116(19), 2110-2118.
Raurich, J. M., Rialp, G., Ibáñez, J.,(2010). Hypercapnic respiratory failure in obesity-hypoventilation syndrome: CO2 response and acetazolamide treatment effects. Respiratory care, 55(11), 1442-1448.
Straus, C., & Similowski, T. (2011). Congenital central hypoventilation syndrome and desogestrel: a call for caution: addendum to “C. Straus, H. Trang, MH Becquemin, P. Touraine, T. Similowski, Chemosensitivity recovery in Ondine's curse syndrome under treatment with desogestrel”[Respir. Physiol. Neurobiol. 171 (2010) 171–174]. Respiratory physiology & neurobiology, 178(2), 357-358.
Amiel, J., Laudier, B., Attie-Bitach, T. (2003). Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nature genetics, 33(4), 459-461.
Goldberg, D. S., & Ludwig, I. H. (1996). Congenital central hypoventilation syndrome: ocular findings in 37 children.
Zelko, F. A., Nelson, M. N., Leurgans, S. E. (2010). Congenital central hypoventilation syndrome: neurocognitive functioning in school age children. Pediatric pulmonology, 45(1), 92-98.
